SCHEMBL298361

SCHEMBL298361

COc1c(NC(=O)c2ccc(C#N)cc2C)cccc1C(=O)Nc1c(Cl)cc(C(F)(C(F)(F)F)C(F)(F)C(F)(F)F)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
LMNA P02545 2/20 0.41
RAB9A P51151 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GPR6 P46095 4/20 0.41
RXFP1 Q9HBX9 3/20 0.39
KMT2A Q03164 3/20 0.38
NR1H4 Q96RI1 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
PKM P14618 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13836070 0.95 GPR6 (0.40) KDM4EALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL299503 0.89 GPR6 (0.39) KDM4EALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL15073366 0.85 ALDH1A1 (0.43) KDM4EALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL13968278 0.83 DHODH (0.42) KDM4EALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL13835132 0.83 ALDH1A1 (0.42) KDM4EALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL3703139 0.82 KMT2A (0.39) KDM4EALDH1A1SMN1; SMN2LMNARXFP1
SCHEMBL29360734 0.82 KMT2A (0.39) KDM4EALDH1A1SMN1; SMN2LMNARXFP1
SCHEMBL297521 0.82 RXFP1 (0.45) KDM4EALDH1A1SMN1; SMN2NPC1LMNA
SCHEMBL29360968 0.80 LRRK2 (0.36) KDM4EALDH1A1SMN1; SMN2KMT2APDE4A
SCHEMBL3706954 0.80 LRRK2 (0.36) KDM4EALDH1A1SMN1; SMN2KMT2APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3339286-A1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2018-06-27 EP disclosed
EP-2427426-B1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2018-02-07 EP disclosed
WO-2013092942-A1 USE OF AMINOBENZAMIDE DERIVATIVES FOR CONTROLLING ANIMAL PARASITES SYNGENTA PARTICIPATIONS AG (CH) 2013-06-27 WO disclosed
US-20120295907-A1 INSECTICIDAL COMPOUNDS SYNGENTA CROP PROTECTION, LLC (US) 2012-11-22 US disclosed
EP-2427426-A1 INSECTICIDAL COMPOUNDS Syngenta Participations AG (CH) 2012-03-14 EP disclosed
WO-2010127928-A1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295907-A1 INSECTICIDAL COMPOUNDS ACHE, AADAC, BCHE KDM4E 1835/4885ALDH1A1 331/4885SMN1; SMN2 1116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.